ARTICLEhttps://harbor.dev.pubfactory.com/view/journals/jnccn/10/12/article-p1459.xmlMeasuring Hope: Patient Expectations of Chemotherapy for Advanced Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/12/article-p1459.pdf2026-04-18Measuring Hope: Patient Expectations of Chemotherapy for Advanced Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/10/12/article-pxxviii.xmlNCCN News2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/12/article-pxxviii.pdf2026-04-18NCCN Newshttps://harbor.dev.pubfactory.com/view/journals/jnccn/10/12/article-pxxxiii.xmlOncology Research Program2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/12/article-pxxxiii.pdf2026-04-18Oncology Research Programhttps://harbor.dev.pubfactory.com/view/journals/jnccn/10/12/article-p1487.xmlNon-Hodgkin’s Lymphomas, Version 3.20122026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/12/article-p1487.pdf2026-04-18Non-Hodgkin’s Lymphomas, Version 3.2012https://harbor.dev.pubfactory.com/view/journals/jnccn/10/12/article-p1477.xmlNeoadjuvant Imatinib for Borderline Resectable GIST2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/12/article-p1477.pdf2026-04-18Neoadjuvant Imatinib for Borderline Resectable GISThttps://harbor.dev.pubfactory.com/view/journals/jnccn/10/12/article-p1468.xmlCancer Survivorship: We’ve Only Just Begun2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/12/article-p1468.pdf2026-04-18Cancer Survivorship: We’ve Only Just Begunhttps://harbor.dev.pubfactory.com/view/journals/jnccn/10/12/article-p1462.xmlAccountable Care Organizations Are No Longer Unicorns, But They Are Still Zebras!2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/12/article-p1462.pdf2026-04-18Accountable Care Organizations Are No Longer Unicorns, But They Are Still Zebras!https://harbor.dev.pubfactory.com/view/journals/jnccn/10/12/article-p1528.xmlRectal Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/12/article-p1528.pdf2026-04-18Rectal Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/10/12/article-p1505.xmlStrategies for Optimizing the Clinical Impact of Immunotherapeutic Agents Such as Sipuleucel-T in Prostate Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/12/article-p1505.pdf2026-04-18Strategies for Optimizing the Clinical Impact of Immunotherapeutic Agents Such as Sipuleucel-T in Prostate Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/10/12/article-p1514.xmlStereotactic Ablative Radiotherapy for Non–Small Cell Lung Cancer: Rationale and Outcomes2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/12/article-p1514.pdf2026-04-18Stereotactic Ablative Radiotherapy for Non–Small Cell Lung Cancer: Rationale and Outcomeshttps://harbor.dev.pubfactory.com/view/journals/jnccn/10/12/article-p1567.xmlControversies in Radiation for Upper Rectal Cancers2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/12/article-p1567.pdf2026-04-18Controversies in Radiation for Upper Rectal Cancershttps://harbor.dev.pubfactory.com/view/journals/jnccn/10/12/article-p1577.xmlMultidisciplinary Management of Early-Stage Rectal Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/12/article-p1577.pdf2026-04-18Multidisciplinary Management of Early-Stage Rectal Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/10/12/article-p1590.xmlSurveillance for Esophageal Cancer: Does it Make Sense?2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/12/article-p1590.pdf2026-04-18Surveillance for Esophageal Cancer: Does it Make Sense?